These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 8979763)
21. Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in predialysis and hemodialysis patients. López-Alcorocho JM; Barril G; Ortiz-Movilla N; Traver JA; Bartolomé J; Sanz P; Selgas R; Carreño V J Med Virol; 2001 Feb; 63(2):103-7. PubMed ID: 11170045 [TBL] [Abstract][Full Text] [Related]
22. Frequencies of GB virus C/hepatitis G virus genomes and of specific antibodies in German risk and non-risk populations. Nübling CM; Bialleck H; Fürsch AJ; Scharrer I; Schramm W; Seifried E; Schmidt U; Staszewski S; Löwer J J Med Virol; 1997 Nov; 53(3):218-24. PubMed ID: 9365885 [TBL] [Abstract][Full Text] [Related]
23. Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alfa. Enomoto M; Nishiguchi S; Fukuda K; Kuroki T; Tanaka M; Otani S; Ogami M; Monna T Hepatology; 1998 May; 27(5):1388-93. PubMed ID: 9581696 [TBL] [Abstract][Full Text] [Related]
24. High prevalence of GB virus C/hepatitis G virus in Kinshasa, Democratic Republic of Congo: a phylogenetic analysis. Liu HF; Muyembe-Tamfum JJ; Dahan K; Desmyter J; Goubau P J Med Virol; 2000 Feb; 60(2):159-65. PubMed ID: 10596015 [TBL] [Abstract][Full Text] [Related]
25. [Prevalence of hepatitis G virus among Tunisian blood donors]. Mastouri M; Safer IL; Pozzetto B; Bourlet T; Khedher M East Mediterr Health J; 2005; 11(5-6):1053-60. PubMed ID: 16761677 [TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of GB virus C/hepatitis G virus in HIV-1-positive intravenous drug users in Belgium. Liu HF; Goderniaux E; Burtonboy G; Goubau P J Hum Virol; 1999; 2(2):115-20. PubMed ID: 10225213 [TBL] [Abstract][Full Text] [Related]
30. Hepatitis G virus: is it a hepatitis virus? Cheung RC; Keeffe EB; Greenberg HB West J Med; 1997 Jul; 167(1):23-33. PubMed ID: 9265860 [TBL] [Abstract][Full Text] [Related]
31. Amplification of GB virus-C/hepatitis G virus RNA with primers from different regions of the viral genome. Kao JH; Chen PJ; Chen W; Hsiang SC; Lai MY; Chen DS J Med Virol; 1997 Apr; 51(4):284-9. PubMed ID: 9093942 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of GBV-C/HGV, a novel 'hepatitis' virus, in patients with aplastic anaemia. Brown KE; Wong S; Young NS Br J Haematol; 1997 May; 97(2):492-6. PubMed ID: 9163622 [TBL] [Abstract][Full Text] [Related]
33. Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan. Liu CJ; Kao JH; Lai MY; Chen PJ; Chu JS; Chen W; Chen DS J Gastroenterol Hepatol; 1999 Apr; 14(4):352-7. PubMed ID: 10207785 [TBL] [Abstract][Full Text] [Related]
34. The clinical significance of the detection of hepatitis GBV-C RNA in the serum of patients with fulminant, presumed viral, hepatitis. Haydon GH; Jarvis LM; Simpson KJ; Hayes PC; Simmonds P J Viral Hepat; 1997 Jan; 4(1):45-9. PubMed ID: 9031064 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of hepatitis G virus in patients with aplastic anemia. Kiem HP; Myerson D; Storb R; McDonald GB; Spurgeon CL; Leisenring W Blood; 1997 Aug; 90(3):1335-6. PubMed ID: 9242573 [No Abstract] [Full Text] [Related]
36. Hepatitis GB virus C. Yoshiba M; Inoue K; Sekiyama K N Engl J Med; 1996 Oct; 335(18):1392-3. PubMed ID: 8927065 [No Abstract] [Full Text] [Related]
37. [Hepatitis G virus (HGBV-C/HGV) as a putative agent for non-A to E hepatitis]. Okamoto H Nihon Rinsho; 1997 Mar; 55(3):515-22. PubMed ID: 9086750 [TBL] [Abstract][Full Text] [Related]
38. Fulminant hepatitis and the new G/GBV-C flavivirus. Hadziyannis SJ J Viral Hepat; 1998 Jan; 5(1):15-9. PubMed ID: 9493512 [TBL] [Abstract][Full Text] [Related]
39. GBV-C/HGV infection and aplastic anaemia. Kao JH; Chen PJ; Lai MY; Chen DS Lancet; 1996 Oct; 348(9033):1032-3. PubMed ID: 8855880 [No Abstract] [Full Text] [Related]
40. Relation between GB virus C/hepatitis G virus and fulminant hepatic failure may be secondary to treatment with contaminated blood and/or blood products. Halasz R; Barkholt L; Lara C; Hultgren C; Ando Y; Broomé U; Fischler B; Nemeth A; Ericzon BG; Sönnerborg A; Sällberg M Gut; 1999 Feb; 44(2):274-8. PubMed ID: 9895390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]